Register to Vote: Rock the Vote, powered by Credo Mobile

HOME

ABOUT US

OUR ISSUES

Federal Budget

Information & Access

Nonprofit Advocacy


PRESS ROOM

ACTION CENTER

PUBLICATIONS

THE WATCHER

OUR BLOGS


SIGN UP

Receive news, updates, and alerts!

DONATE

Help support our work


OTHER SITES

FedSpending.org

RTK NET

NPAction

Working Group on Community Right-to-Know

Citizens for Sensible Safeguards

Open the Government

OMB Watch Logo

"[P]eople acting in a group can accomplish things which no individual acting alone could even hope to bring about." - FDR

Home :  Regulatory Policy :  RegWatch : 
RegWatch:     

News & Analysis | REG•WATCH Blog | Press Room

 R    E    G    •    W    A    T    C    H 


Tuesday, June 27, 2006

U.S. Promoting Paralysis by Analysis Worldwide
What's bad for America is being touted as great for the rest of the world:
By year's end, the European Union is expected to adopt REACH, a proposal that would "require manufacturers to test industrial chemicals used in the manufacturing process to gather health and safety data." REACH stands for "Registration, Evaluation and Authorization of Chemicals." The bill "has prompted a U.S.-led coalition of 13 countries to step up lobbying efforts to make the final measure more amenable to industry," reports the Wall Street Journal. "The diplomatic missions of the U.S., Japan, Australia, India and other countries issues a length joint critique of the proposed law this month, saying certain provisions would disrupt international trade without offering clear environmental benefits." C. Boyden Gray, the U.S. ambassador to the EU and former chair of FreedomWorks and Citizens for a Sound Economy, said European policymakers "never did a proper impact assessment to evaluate the risk-versus-benefit status of this legislation."
Website: Wall Street Journal (sub req'd), June 27, 2006
[Via Center for Media and Democracy - Publishers of PR Watch]


Posted by Robert Shull, 02:25:38 PM



Monday, June 26, 2006

Drop in FDA Enforcement
Remember "oversight"? It's Congress's job. Although not in the majority, the Waxman-led Democrats of the House Government Reform Committee continue to demonstrate that oversight is an important congressional responsibility. Check out the latest report, Prescription for Harm: The Decline in FDA Enforcement Activity:
A new report by Rep. Henry A. Waxman examines how the Bush Administration has carried out FDA's historic enforcement responsibilities. The report is the result of a 15-month investigation that included a review of thousands of pages of internal agency enforcement records. It finds that there has been a precipitous drop in FDA enforcement actions over the last five years.
[Via Government Reform Democrats]


Posted by Robert Shull, 12:18:30 PM



Wednesday, June 14, 2006

"Atypical Mad Cow" Not a Surprise, After All
Reports of an atypical strain of mad cow disease need not have come as such a surprise, according to the folks who publish PR Watch:

The small scientific world of prion researchers -- the scientists who investigate "transmissible spongiform encephalopathies" (TSE) such as mad cow disease in cattle and Creutzfeldt-Jakob Disease (CJD) in humans -- is abuzz. That's because the two confirmed cases of US mad cow disease in Texas and Alabama are an "atypical" strain different from the British strain. This really should not be surprising. Sheldon Rampton and I reported in 1997 that very strong evidence of an "atypical" TSE disease in US cattle goes back to the 1985 work of Dr. Richard Marsh, the researcher to whom we dedicated our book Mad Cow USA. Even before Britain confirmed its first case of mad cow, Marsh was investigating a similar disease he traced to Wisconsin dairy cattle, confirming suspicions among US scientists since the 1960s that a deadly TSE disease in mink -- transmissible mink encephalopathy or TME -- resulted from their eating dairy cattle.

[Via Center for Media and Democracy - Publishers of PR Watch]


Posted by Robert Shull, 01:44:34 PM




Latest Entries by Theme

All Themes

Enforcement

About This Blog

Rollbacks

Safety

Industry Influence

Cost-Benefit Analysis

In Congress

Publications

Consumer Issues

Environment

Public Health

In the Courts

Oversight

In the White House

Most Recent Entries for RegWatch

Bush Administration Backs Off SCHIP Restrictions

Bush Signs Consumer Product Safety Bill

Bush Administration Cuts Habitat for Spotted Owl

Bush Trying Last-Minute Changes to Endangered Species Act

For EPA Staff Trying to Protect the Planet, "Disappointment is Profound"

Consumer Product Bill Delivers Win for Consumers

Will New FDA Guidelines Really Reduce Conflicts of Interest?

Crane Rule Held Back by Bush Administration Ideology

Senate Passes Product Safety Bill

Product Safety Bill Overwhelmingly Approved by House

Archived Entries for Public Health

August

July

June

May

April

March

February

January

December, 2007

November, 2007

October, 2007

September, 2007

August, 2007

July, 2007

June, 2007

May, 2007

April, 2007

March, 2007

February, 2007

January, 2007

December, 2006

November, 2006

October, 2006

September, 2006

August, 2006

June, 2006

May, 2006

April, 2006

March, 2006

January, 2006

December, 2005

November, 2005

October, 2005

September, 2005

August, 2005

July, 2005

June, 2005

May, 2005

April, 2005

March, 2005

February, 2005

January, 2005

December, 2004

November, 2004

October, 2004